RxDoctor Payments Data

Jonathon Wenke

Family · Bay Shore, NYNPI 1124681242

Payments from drug & device makers

$2,447in general payments, 2019–2025

Across 118 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$633
  • Amgen$269
  • AbbVie$220
  • Merck$168
  • Daiichi Sankyo Inc.$137
  • Pfizer$122
  • plus $898 from 16 others

What the payments were for

  • Food & beverage$2,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,447 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban564$749,936
Repatha SureclickEvolocumab225$246,363
XareltoRivaroxaban104$128,660
EntrestoSacubitril/Valsartan75$106,784
MultaqDronedarone Hcl58$102,864
FarxigaDapagliflozin Propanediol56$77,535
Praluent PenAlirocumab52$49,231
BrilintaTicagrelor32$39,456
JardianceEmpagliflozin32$36,313
VascepaIcosapent Ethyl23$19,122
Metoprolol Succinate1,134$18,472
NexlizetBempedoic Acid/Ezetimibe14$16,144
NexletolBempedoic Acid13$15,279
Rosuvastatin Calcium871$14,131
Ezetimibe488$14,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$122$749,936564 claims
Johnson & JohnsonXarelto$51$128,660104 claims
AstraZenecaFarxiga, Brilinta$113$116,99288 claims
NovartisEntresto$633$106,78475 claims
Boehringer IngelheimJardiance$82$36,31332 claims
Esperion Therapeutics, Inc.Nexlizet, Nexletol$80$31,42327 claims
Novo NordiskOzempic$47$13,92811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in Bay Shore

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →